Cardlytics Inc reports results for the quarter ended June 30 - Earnings Summary

Cardlytics

05/08/2026 22:02

Cardlytics Inc CDLX.OQ reported a quarterly adjusted loss of 81 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-1.30.  The mean expectation of three analysts for the quarter was for a loss of $1.35 per share. Wall Street expected results to range from $-1.80 to -90 cents per share.
Revenue fell 41.7% to $36.88 million from a year ago; analysts expected $37.00 million. 
Cardlytics Inc's reported EPS for the quarter was a loss of $1.50​.
The company reported a quarterly loss of $14.88 million.
Cardlytics Inc shares had fallen by 10.5% this quarter and lost 65.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 17.3% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the software peer group is  "buy."
Wall Street's median 12-month price target for Cardlytics Inc is $10.00, about 59.8% above its last closing price of $4.02
This summary was machine generated from LSEG data August 5 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-1.35
-0.81
Beat
Mar. 31 2026 
-2.13
-1.10
Beat
Dec. 31 2025 
-0.70
0.30
Beat
Sep. 30 2025 
-1.50
-0.70
Beat